EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy

por Birch, David G., Benz, Matthew S., Miller, Daniel M., Antoszyk, Andrew N., Markoff, Joseph, Kozma, Petra, Meunier, Esmeralda, Sergott, Robert C.
Publicado 2018

Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway

por Miller, Daniel M., Rahill, Brian M., Boss, Jeremy M., Lairmore, Michael D., Durbin, Joan E., Waldman, James W., Sedmak, Daniel D.
Publicado 1998

Comparison of outcomes: scleral buckling and pars plana vitrectomy versus vitrectomy alone for primary repair of rhegmatogenous retinal detachment

por Lindsell, Luke B, Sisk, Robert A, Miller, Daniel M, Foster, Robert E, Petersen, Michael R, Riemann, Christopher D, Hutchins, Robert K
Publicado 2016

Macrophage Activation Associated with Chronic Murine Cytomegalovirus Infection Results in More Severe Experimental Choroidal Neovascularization

por Cousins, Scott W., Espinosa-Heidmann, Diego G., Miller, Daniel M., Pereira-Simon, Simone, Hernandez, Eleut P., Chien, Hsin, Meier-Jewett, Courtney, Dix, Richard D.
Publicado 2012

Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia

por Berger, Tyler A, Manry, Matthew W, Lindsell, Lucas B, Osher, James M, Miller, Daniel M, Foster, Robert E, Riemann, Christopher D, Petersen, Michael R, Sisk, Robert A
Publicado 2021